Search Orphan Drug Designations and Approvals
-
Generic Name: | Sorivudine |
---|---|
Date Designated: | 11/09/1995 |
Orphan Designation: | Treatment of herpes zoster (shingles) in immunocompromised patients |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Bristol-Myers Squibb 5 Research Parkway P.O. Box 5100 Wallingford, Connecticut 06492 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-